Physician profile
Michael L Gilbert
NPI 1386646065
$4,435.18
in general payments reported to CMS, 2019-2025
16 companies · $794 in 2025
The $794 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,961 · 2020: $440 · 2021: $221 · 2022: $129 · 2023: $568 · 2024: $322 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,684.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,274.83 | 2019-2024 | Tecnis Simplicity, Whitestar Phaco Handpiece, Tecnis Iol |
| Alcon Vision LLC | $690.53 | 2019-2025 | Clareon Panoptix Pro, Rocklatan, Tryptyr |
| Glaukos Corporation | $412.85 | 2019-2025 | Idosetr, Idose, Istent Infinite |
| Rxsight INC | $164.80 | 2024-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Ivantis, INC | $163.12 | 2020 | |
| Bausch & Lomb Americas INC. | $146.09 | 2023-2024 | Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $144.04 | 2019 | |
| Biotissue Holdings INC. | $122.12 | 2025 | |
| Allergan, INC. | $69.83 | 2019 | |
| Carl Zeiss Meditec, INC. | $63.20 | 2019 | |
| Sun Pharmaceutical Industries INC. | $49.04 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $36.07 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $34.44 | 2024 | Eylea Hd, Eylea |
| Dompe US, INC. | $30.44 | 2024 | Oxervate |
| Quidel Corporation | $17.14 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.64 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.